
TY  - JOUR
TI  - Synopses of papers presented at the 156th meeting of the Pathological Society of Great Britain and Ireland
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 154
IS  - 1
SN  - 0022-3417
UR  - https://doi.org/10.1002/path.1711540106
DO  - doi:10.1002/path.1711540106
SP  - 35A
EP  - 109A
PY  - 1988
ER  - 

TY  - JOUR
TI  - Tuesday Poster Session
JO  - Journal of Neurochemistry
VL  - 110
IS  - s2
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1471-4159.2009.06239.x
DO  - doi:10.1111/j.1471-4159.2009.06239.x
SP  - 90
EP  - 131
PY  - 2009
ER  - 

TY  - JOUR
TI  - P679 - P940
JO  - Clinical Microbiology and Infection
VL  - 12
IS  - s4
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1470-9465.2006.12_4_1428.x
DO  - doi:10.1111/j.1470-9465.2006.12_4_1428.x
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstracts of the IPITA-IXA-CTS 2015 Joint Congress November 15–19, 2015, Melbourne, Australia
JO  - Xenotransplantation
JA  - Xenotransplantation
VL  - 22
IS  - S1
SN  - 0908-665X
UR  - https://doi.org/10.1111/xen.12205
DO  - doi:10.1111/xen.12205
SP  - S48
EP  - S120
PY  - 2015
ER  - 

TY  - JOUR
AU  - DEWANJEE, MRINAL K.
TI  - Methods of Assessment of Thrombosis in Vivo
JO  - Annals of the New York Academy of Sciences
VL  - 516
IS  - 1
SN  - 0077-8923
UR  - https://doi.org/10.1111/j.1749-6632.1987.tb33073.x
DO  - doi:10.1111/j.1749-6632.1987.tb33073.x
SP  - 541
EP  - 571
PY  - 1987
ER  - 

TY  - JOUR
TI  - XXIIIrd Congress of the ISBT Abstracts
JO  - Vox Sanguinis
VL  - 67
IS  - s2
SN  - 0042-9007
UR  - https://doi.org/10.1111/j.1423-0410.1994.tb03669.x
DO  - doi:10.1111/j.1423-0410.1994.tb03669.x
SP  - 1
EP  - 174
PY  - 1994
ER  - 

TY  - JOUR
TI  - Oral presentations
JO  - Cytopathology
VL  - 16
IS  - s2
SN  - 0956-5507
UR  - https://doi.org/10.1111/j.1365-2303.2005.00291_1.x
DO  - doi:10.1111/j.1365-2303.2005.00291_1.x
SP  - 1
EP  - 30
PY  - 2005
ER  - 

TY  - JOUR
AU  - Ullery, John C.
AU  - Pomeroy, Thomas
TI  - Management of gynecologic cancer
JO  - CA: A Cancer Journal for Clinicians
JA  - CA: A Cancer Journal for Clinicians
VL  - 12
IS  - 4
SN  - 0007-9235
UR  - https://doi.org/10.3322/canjclin.12.4.122
DO  - doi:10.3322/canjclin.12.4.122
SP  - 122
EP  - 138
PY  - 1962
ER  - 

TY  - JOUR
TI  - Stress Regulation and Homeostasis, Aging, Radiation, Oxidative Stress, Inflammation
JO  - Journal of Neurochemistry
VL  - 87
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1046/j.1474-1644.2003.2175_15.x
DO  - doi:10.1046/j.1474-1644.2003.2175_15.x
SP  - 152
EP  - 152
PY  - 2003
ER  - 

TY  - JOUR
AU  - Mealey, Brian L.
TI  - Periodontal Implications: Medically Compromised Patients
JO  - Annals of Periodontology
JA  - Annals of Periodontology
VL  - 1
IS  - 1
SN  - 1553-0841
UR  - https://doi.org/10.1902/annals.1996.1.1.256
DO  - doi:10.1902/annals.1996.1.1.256
SP  - 256
EP  - 321
PY  - 1996
ER  - 

TY  - JOUR
TI  - 12TH ANNUAL STATE OF THE ART WINTER SYMPOSIUM
JO  - American Journal of Transplantation
VL  - 12
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2011.03951.x
DO  - doi:10.1111/j.1600-6143.2011.03951.x
SP  - 49
EP  - 95
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster presentations
JO  - Cytopathology
VL  - 16
IS  - s2
SN  - 0956-5507
UR  - https://doi.org/10.1111/j.1365-2303.2005.00291_2.x
DO  - doi:10.1111/j.1365-2303.2005.00291_2.x
SP  - 31
EP  - 93
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstracts 1030–1231
JO  - Hepatology
JA  - Hepatology
VL  - 52
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.23993
DO  - doi:10.1002/hep.23993
SP  - 818A
EP  - 918A
PY  - 2010
ER  - 

TY  - JOUR
TI  - SYMPOSIA
JO  - Fundamental & Clinical Pharmacology
VL  - 13
IS  - S1
SN  - 0767-3981
UR  - https://doi.org/10.1111/j.1472-8206.1999.tb00382.x
DO  - doi:10.1111/j.1472-8206.1999.tb00382.x
SP  - 11s
EP  - 113s
PY  - 1999
ER  - 

TY  - JOUR
TI  - Poster session 1: Apheresis
JO  - Vox Sanguinis
VL  - 95
IS  - s1
SN  - 0042-9007
UR  - https://doi.org/10.1111/j.1423-0410.2008.01056.x
DO  - doi:10.1111/j.1423-0410.2008.01056.x
SP  - 74
EP  - 326
PY  - 2008
ER  - 

AU  - Tidball, James G.
C7  - pp. 2029-2062
TI  - Mechanisms of Muscle Injury, Repair, and Regeneration
UR  - https://doi.org/10.1002/cphy.c100092
DO  - doi:10.1002/cphy.c100092
SP  - 2029-2062
PY  - 2008
AB  - Abstract Skeletal muscle continuously adapts to changes in its mechanical environment through modifications in gene expression and protein stability that affect its physiological function and mass. However, mechanical stresses commonly exceed the parameters that induce adaptations, producing instead acute injury. Furthermore, the relatively superficial location of many muscles in the body leaves them further vulnerable to acute injuries by exposure to extreme temperatures, contusions, lacerations or toxins. In this article, the molecular, cellular, and mechanical factors that underlie muscle injury and the capacity of muscle to repair and regenerate are presented. Evidence shows that muscle injuries that are caused by eccentric contractions result from direct mechanical damage to myofibrils. However, muscle pathology following other acute injuries is largely attributable to damage to the muscle cell membrane. Many feaures in the injury-repair-regeneration cascade relate to the unregulated influx of calcium through membrane lesions, including: (i) activation of proteases and hydrolases that contribute muscle damage, (ii) activation of enzymes that drive the production of mitogens and motogens for muscle and immune cells involved in injury and repair, and (iii) enabling protein-protein interactions that promote membrane repair. Evidence is also presented to show that the myogenic program that is activated by acute muscle injury and the inflammatory process that follows are highly coordinated, with myeloid cells playing a central role in modulating repair and regeneration. The early-invading, proinflammatory M1 macrophages remove debris caused by injury and express Th1 cytokines that play key roles in regulating the proliferation, migration, and differentiation of satellite cells. The subsequent invasion by anti-inflammatory, M2 macrophages promotes tissue repair and attenuates inflammation. Although this system provides an effective mechanism for muscle repair and regeneration following acute injury, it is dysregulated in chronic injuries. In this article, the process of muscle injury, repair and regeneration that occurs in muscular dystrophy is used as an example of chronic muscle injury, to highlight similarities and differences between the injury and repair processes that occur in acutely and chronically injured muscle. ? 2011 American Physiological Society. Compr Physiol 1:2029-2062, 2011.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - International Journal of Rheumatic Diseases
JA  - Int J Rheum Dis
VL  - 17
IS  - s1
UR  - https://doi.org/10.1111/1756-185x.12344
DO  - doi:10.1111/1756-185x.12344
SP  - 1
EP  - 133
PY  - 2014
ER  - 

TY  - JOUR
AU  - Zhang, Jingya
AU  - Kramer, Elisabeth G.
AU  - Asp, Linnea
AU  - Dutta, Dipankar J.
AU  - Navrazhina, Kristina
AU  - Pham, Trinh
AU  - Mariani, John N.
AU  - Argaw, Azeb Tadesse
AU  - Melendez-Vasquez, Carmen V.
AU  - John, Gareth R.
TI  - Promoting myelin repair and return of function in multiple sclerosis
JO  - FEBS Letters
VL  - 585
IS  - 23
UR  - https://doi.org/10.1016/j.febslet.2011.08.017
DO  - doi:10.1016/j.febslet.2011.08.017
SP  - 3813
EP  - 3820
KW  - Multiple sclerosis
KW  - Demyelination
KW  - Axonal transection
KW  - Regeneration
KW  - Neuroprotection
PY  - 2011
AB  - Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS. Conduction block in demyelinated axons underlies early neurological symptoms, but axonal transection and neuronal loss are believed to be responsible for more permanent chronic deficits. Several therapies are approved for treatment of relapsing-remitting MS, all of which are immunoregulatory and clinically proven to reduce the rate of lesion formation and exacerbation. However, existing approaches are only partially effective in preventing the onset of disability in MS patients, and novel treatments to protect myelin-producing oligodendrocytes and enhance myelin repair may improve long-term outcomes. Studies in vivo in genetically modified mice have assisted in the characterization of mechanisms underlying the generation of neuropathology in MS patients, and have identified potential avenues for oligodendrocyte protection and myelin repair. However, no treatments are yet approved that target these areas directly, and in addition, the relationship between demyelination and axonal transection in the lesions of the disease remains unclear. Here, we review translational research targeting oligodendrocyte protection and myelin repair in models of autoimmune demyelination, and their potential relevance as therapies in MS.
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Reproduction in Domestic Animals
VL  - 45
IS  - s3
UR  - https://doi.org/10.1111/j.1439-0531.2010.01654_3.x
DO  - doi:10.1111/j.1439-0531.2010.01654_3.x
SP  - 63
EP  - 113
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - The FEBS Journal
VL  - 274
IS  - s1
UR  - https://doi.org/10.1111/j.0014-2956.2007.05861_3.x
DO  - doi:10.1111/j.0014-2956.2007.05861_3.x
SP  - 133
EP  - 220
PY  - 2007
ER  - 
